Drug Type Small molecule drug |
Synonyms Compound 51(University of Chinese Academy of Sciences) |
Target |
Mechanism ERs degraders(Estrogen receptors degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H29F2NO3S |
InChIKeyBKDGYCGJTOTOOY-LEAFIULHSA-N |
CAS Registry3035311-43-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | CN | 28 Nov 2024 |